FDA Inspection
Alexza Pharmaceuticals, Inc.Alexza Pharmaceuticals, Inc. – FDA Inspection, Aug 20, 2010
Record Details
This FDA Inspection record concerns Alexza Pharmaceuticals, Inc., with an inspection on August 20, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Alexza Pharmaceuticals, Inc.
- Inspection Date
- August 20, 2010
- Product Type
- Drugs
View Company Profile
ID · bd4e9727-c50c-4d2d-b6f8-dedb5eee4e13
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 675646
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Alexza Pharmaceuticals, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 19, 2025 | Not classified | San Francisco District Office | |
| August 1, 2025 | Not classified | San Francisco District Office | |
| December 22, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 26, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 21, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Alexza Pharmaceuticals, Inc.
- FDA Inspection 1300206 - 2025-12-19
- FDA Inspection 1281572 - 2025-08-01
- FDA Inspection 1227246 - 2023-12-22
- FDA Inspection 1109014 - 2019-09-26
- FDA Inspection 926541 - 2015-05-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.